Cargando…
Hyper-inflammatory Syndrome in a Child With COVID-19 Treated Successfully With Intravenous Immunoglobulin and Tocilizumab
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer India
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387261/ https://www.ncbi.nlm.nih.gov/pubmed/32393681 http://dx.doi.org/10.1007/s13312-020-1901-z |
_version_ | 1783564085479079936 |
---|---|
author | Balasubramanian, S. Nagendran, T. M. Ramachandran, B. Ramanan, A. V. |
author_facet | Balasubramanian, S. Nagendran, T. M. Ramachandran, B. Ramanan, A. V. |
author_sort | Balasubramanian, S. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7387261 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer India |
record_format | MEDLINE/PubMed |
spelling | pubmed-73872612020-07-29 Hyper-inflammatory Syndrome in a Child With COVID-19 Treated Successfully With Intravenous Immunoglobulin and Tocilizumab Balasubramanian, S. Nagendran, T. M. Ramachandran, B. Ramanan, A. V. Indian Pediatr Clinical Case Letters Springer India 2020-05-10 2020 /pmc/articles/PMC7387261/ /pubmed/32393681 http://dx.doi.org/10.1007/s13312-020-1901-z Text en © Indian Academy of Pediatrics 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Clinical Case Letters Balasubramanian, S. Nagendran, T. M. Ramachandran, B. Ramanan, A. V. Hyper-inflammatory Syndrome in a Child With COVID-19 Treated Successfully With Intravenous Immunoglobulin and Tocilizumab |
title | Hyper-inflammatory Syndrome in a Child With COVID-19 Treated Successfully With Intravenous Immunoglobulin and Tocilizumab |
title_full | Hyper-inflammatory Syndrome in a Child With COVID-19 Treated Successfully With Intravenous Immunoglobulin and Tocilizumab |
title_fullStr | Hyper-inflammatory Syndrome in a Child With COVID-19 Treated Successfully With Intravenous Immunoglobulin and Tocilizumab |
title_full_unstemmed | Hyper-inflammatory Syndrome in a Child With COVID-19 Treated Successfully With Intravenous Immunoglobulin and Tocilizumab |
title_short | Hyper-inflammatory Syndrome in a Child With COVID-19 Treated Successfully With Intravenous Immunoglobulin and Tocilizumab |
title_sort | hyper-inflammatory syndrome in a child with covid-19 treated successfully with intravenous immunoglobulin and tocilizumab |
topic | Clinical Case Letters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387261/ https://www.ncbi.nlm.nih.gov/pubmed/32393681 http://dx.doi.org/10.1007/s13312-020-1901-z |
work_keys_str_mv | AT balasubramanians hyperinflammatorysyndromeinachildwithcovid19treatedsuccessfullywithintravenousimmunoglobulinandtocilizumab AT nagendrantm hyperinflammatorysyndromeinachildwithcovid19treatedsuccessfullywithintravenousimmunoglobulinandtocilizumab AT ramachandranb hyperinflammatorysyndromeinachildwithcovid19treatedsuccessfullywithintravenousimmunoglobulinandtocilizumab AT ramananav hyperinflammatorysyndromeinachildwithcovid19treatedsuccessfullywithintravenousimmunoglobulinandtocilizumab |